231 related articles for article (PubMed ID: 20683038)
1. Soluble carbonic anhydrase IX is not an independent prognostic factor in human renal cell carcinoma.
Papworth K; Sandlund J; Grankvist K; Ljungberg B; Rasmuson T
Anticancer Res; 2010 Jul; 30(7):2953-7. PubMed ID: 20683038
[TBL] [Abstract][Full Text] [Related]
2. Prognostic impact of carbonic anhydrase IX expression in human renal cell carcinoma.
Sandlund J; Oosterwijk E; Grankvist K; Oosterwijk-Wakka J; Ljungberg B; Rasmuson T
BJU Int; 2007 Sep; 100(3):556-60. PubMed ID: 17608827
[TBL] [Abstract][Full Text] [Related]
3. Carbonic Anhydrase IX is not a predictor of outcomes in non-metastatic clear cell renal cell carcinoma - a digital analysis of tissue microarray.
Zerati M; Leite KR; Pontes-Junior J; Segre CC; Reis ST; Srougi M; Dall'Oglio MF
Int Braz J Urol; 2013; 39(4):484-92. PubMed ID: 24054396
[TBL] [Abstract][Full Text] [Related]
4. Quantification of carbonic anhydrase IX expression in serum and tissue of renal cell carcinoma patients using enzyme-linked immunosorbent assay: prognostic and diagnostic potentials.
Zhou GX; Ireland J; Rayman P; Finke J; Zhou M
Urology; 2010 Feb; 75(2):257-61. PubMed ID: 19963243
[TBL] [Abstract][Full Text] [Related]
5. Serum carbonic anhydrase 9 level is associated with postoperative recurrence of conventional renal cell cancer.
Li G; Feng G; Gentil-Perret A; Genin C; Tostain J
J Urol; 2008 Aug; 180(2):510-3; discussion 513-4. PubMed ID: 18550116
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of serum CA9 in patients with metastatic clear cell renal cell carcinoma under targeted therapy.
Gigante M; Li G; Ferlay C; Perol D; Blanc E; Paul S; Zhao A; Tostain J; Escudier B; Negrier S; Genin C
Anticancer Res; 2012 Dec; 32(12):5447-51. PubMed ID: 23225450
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic implications of transcription factor Pax 2 protein and transmembrane enzyme complex carbonic anhydrase IX immunoreactivity in adult renal epithelial neoplasms.
Gupta R; Balzer B; Picken M; Osunkoya AO; Shet T; Alsabeh R; Luthringer D; Paner GP; Amin MB
Am J Surg Pathol; 2009 Feb; 33(2):241-7. PubMed ID: 18941400
[TBL] [Abstract][Full Text] [Related]
8. Carbonic anhydrase IX is an independent predictor of survival in advanced renal clear cell carcinoma: implications for prognosis and therapy.
Bui MH; Seligson D; Han KR; Pantuck AJ; Dorey FJ; Huang Y; Horvath S; Leibovich BC; Chopra S; Liao SY; Stanbridge E; Lerman MI; Palotie A; Figlin RA; Belldegrun AS
Clin Cancer Res; 2003 Feb; 9(2):802-11. PubMed ID: 12576453
[TBL] [Abstract][Full Text] [Related]
9. Aberrant expression of membranous carbonic anhydrase IX (CAIX) is associated with unfavorable disease course in papillary and clear cell renal cell carcinoma.
Büscheck F; Fraune C; Simon R; Kluth M; Hube-Magg C; Möller-Koop C; Shadanpour N; Bannenberg C; Eichelberg C; Höflmayer D; Clauditz T; Wittmer C; Wilczak W; Sauter G; Fisch M; Rink M; Eichenauer T
Urol Oncol; 2018 Dec; 36(12):531.e19-531.e25. PubMed ID: 30322727
[TBL] [Abstract][Full Text] [Related]
10. Carbonic anhydrase IX as a specific biomarker for clear cell renal cell carcinoma: comparative study of Western blot and immunohistochemistry and implications for diagnosis.
Giménez-Bachs JM; Salinas-Sánchez AS; Serrano-Oviedo L; Nam-Cha SH; Rubio-Del Campo A; Sánchez-Prieto R
Scand J Urol Nephrol; 2012 Oct; 46(5):358-64. PubMed ID: 22571179
[TBL] [Abstract][Full Text] [Related]
11. Expression of carbonic anhydrase IX in genitourinary and adrenal tumours.
Donato DP; Johnson MT; Yang XJ; Zynger DL
Histopathology; 2011 Dec; 59(6):1229-39. PubMed ID: 22175902
[TBL] [Abstract][Full Text] [Related]
12. Carbonic anhydrase IX is not an independent predictor of outcome for patients with clear cell renal cell carcinoma.
Leibovich BC; Sheinin Y; Lohse CM; Thompson RH; Cheville JC; Zavada J; Kwon ED
J Clin Oncol; 2007 Oct; 25(30):4757-64. PubMed ID: 17947723
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of carbonic anhydrase IX and KI67 as predictors of survival for renal clear cell carcinoma.
Bui MH; Visapaa H; Seligson D; Kim H; Han KR; Huang Y; Horvath S; Stanbridge EJ; Palotie A; Figlin RA; Belldegrun AS
J Urol; 2004 Jun; 171(6 Pt 1):2461-6. PubMed ID: 15126876
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical Panel for Differentiating Renal Cell Carcinoma with Clear and Papillary Features.
Alshenawy HA
Pathol Oncol Res; 2015 Sep; 21(4):893-9. PubMed ID: 25712789
[TBL] [Abstract][Full Text] [Related]
15. [Comment to "Immunohistochemical expression of microvascular density and carbonic anhidrase IX in renal carcinoma. Relation to histological type and tumoral progression"].
Salinas AS
Actas Urol Esp; 2011 Feb; 35(2):87-8. PubMed ID: 21288602
[No Abstract] [Full Text] [Related]
16. Hypoxia-regulated carbonic anhydrase IX expression is associated with poor survival in patients with invasive breast cancer.
Hussain SA; Ganesan R; Reynolds G; Gross L; Stevens A; Pastorek J; Murray PG; Perunovic B; Anwar MS; Billingham L; James ND; Spooner D; Poole CJ; Rea DW; Palmer DH
Br J Cancer; 2007 Jan; 96(1):104-9. PubMed ID: 17213826
[TBL] [Abstract][Full Text] [Related]
17. Carbonic anhydrase IX expression in renal neoplasms: correlation with tumor type and grade.
Genega EM; Ghebremichael M; Najarian R; Fu Y; Wang Y; Argani P; Grisanzio C; Signoretti S
Am J Clin Pathol; 2010 Dec; 134(6):873-9. PubMed ID: 21088149
[TBL] [Abstract][Full Text] [Related]
18. Soluble form of carbonic anhydrase IX (CA IX) in the serum and urine of renal carcinoma patients.
Závada J; Závadová Z; Zat'ovicová M; Hyrsl L; Kawaciuk I
Br J Cancer; 2003 Sep; 89(6):1067-71. PubMed ID: 12966427
[TBL] [Abstract][Full Text] [Related]
19. Role of carbonic anhydrase IX, α-methylacyl coenzyme a racemase, cytokeratin 7, and galectin-3 in the evaluation of renal neoplasms: a tissue microarray immunohistochemical study.
Bing Z; Lal P; Lu S; Ziober A; Tomaszewski JE
Ann Diagn Pathol; 2013 Feb; 17(1):58-62. PubMed ID: 22898056
[TBL] [Abstract][Full Text] [Related]
20. Multilocular cystic renal cell carcinoma: similarities and differences in immunoprofile compared with clear cell renal cell carcinoma.
Williamson SR; Halat S; Eble JN; Grignon DJ; Lopez-Beltran A; Montironi R; Tan PH; Wang M; Zhang S; Maclennan GT; Baldridge LA; Cheng L
Am J Surg Pathol; 2012 Oct; 36(10):1425-33. PubMed ID: 22982885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]